# Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery

> **NCT02103114** · PHASE2 · COMPLETED · sponsor: **Duke University** · enrollment: 45 (actual)

## Conditions studied

- ATIII Deficiency

## Interventions

- **DRUG:** Anti-thrombin III
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02103114
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-06-27
- **Final completion:** 2016-07-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02103114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02103114, "Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02103114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*